110
Participants
Start Date
August 22, 2024
Primary Completion Date
December 29, 2026
Study Completion Date
December 29, 2027
ALTA2618
Oral ALTA2618 tablets will be administered at protocol-defined dose
RECRUITING
Research Site, Taipei
RECRUITING
Research Site, Changhua
RECRUITING
Research Site, Randwick
RECRUITING
Research Site, Blacktown
RECRUITING
Research Site, Malvern
RECRUITING
Research Site, South Brisbane
RECRUITING
Research Site, Nedlands
RECRUITING
Research Site, New York
RECRUITING
Research Site, Taipei
RECRUITING
Research Site, Mineola
RECRUITING
Research Site, Seoul
RECRUITING
Research Site, Caen
RECRUITING
Research Site, Fairfax
RECRUITING
Research Site, Madrid
RECRUITING
Research Site, Madrid
RECRUITING
Research Site, Atlanta
RECRUITING
Research Site, Sarasota
RECRUITING
Research Site, Nashville
RECRUITING
Research Site, Maumee
RECRUITING
Research Site, Saint-Herblain
RECRUITING
Research Site, Valencia
RECRUITING
Research Site, Madison
RECRUITING
Research Site, St Louis
WITHDRAWN
Research Site, Dallas
RECRUITING
Research Site, Houston
RECRUITING
Research Site #2, San Antonio
RECRUITING
Research Site, San Antonio
RECRUITING
Research Site, Denver
RECRUITING
Research Site, Los Angeles
RECRUITING
Research Site, La Jolla
RECRUITING
Research Site, Villejuif
RECRUITING
Research Site, Boston
RECRUITING
Research Site, Boston
RECRUITING
Research Site, Kyoto
RECRUITING
Research Site, Matsuyama
RECRUITING
Research Site, Shizuoka
RECRUITING
Research Site, Tokyo
RECRUITING
Research Site, Seoul
RECRUITING
Research Site, Seoul
RECRUITING
Research Site, Seoul
RECRUITING
Research Site, Seoul
RECRUITING
Research Site, Barcelona
RECRUITING
Research Site, Barcelona
RECRUITING
Research Site, Barcelona
RECRUITING
Research Site, London
RECRUITING
Research Site, London
RECRUITING
Research Site, London
RECRUITING
Research Site, Manchester
RECRUITING
Research Site, Sutton
Lead Sponsor
Alterome Therapeutics, Inc.
INDUSTRY